Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292291574> ?p ?o ?g. }
- W4292291574 endingPage "5791" @default.
- W4292291574 startingPage "5774" @default.
- W4292291574 abstract "Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resource allocation through a systematic value assessment of health technology. This paper reviews the challenges in conducting HTA for cancer medicines arising from oncology trial designs and uncertainties of safety-efficacy data.Multiple databases (PubMed, Scopus and Google Scholar) and grey literature (public health agencies and governmental reports) were searched to inform this policy narrative review.A lack of robust efficacy-safety data from clinical trials and other relevant sources of evidence has made HTA for cancer medicines challenging. The approval of cancer medicines through expedited pathways has increased in recent years, in which surrogate endpoints or biomarkers for patient selection have been widely used. Using these surrogate endpoints has created uncertainties in translating surrogate measures into patient-centric clinically (survival and quality of life) and economically (cost-effectiveness and budget impact) meaningful outcomes, with potential effects on diverting scarce health resources to low-value or detrimental interventions. Potential solutions include policy harmonization between regulatory and HTA authorities, commitment to generating robust post-marketing efficacy-safety data, managing uncertainties through risk-sharing agreements, and using value frameworks.A lack of robust efficacy-safety data is a central problem for conducting HTA of cancer medicines, potentially resulting in misinformed resource allocation." @default.
- W4292291574 created "2022-08-19" @default.
- W4292291574 creator A5003643754 @default.
- W4292291574 creator A5003897511 @default.
- W4292291574 creator A5024096995 @default.
- W4292291574 creator A5032941280 @default.
- W4292291574 creator A5035150606 @default.
- W4292291574 creator A5054056965 @default.
- W4292291574 creator A5063528132 @default.
- W4292291574 creator A5067129820 @default.
- W4292291574 creator A5069322918 @default.
- W4292291574 creator A5074257304 @default.
- W4292291574 date "2022-08-16" @default.
- W4292291574 modified "2023-10-15" @default.
- W4292291574 title "Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments" @default.
- W4292291574 cites W1810662963 @default.
- W4292291574 cites W1898655152 @default.
- W4292291574 cites W1985046983 @default.
- W4292291574 cites W2028590696 @default.
- W4292291574 cites W2030059292 @default.
- W4292291574 cites W2076296993 @default.
- W4292291574 cites W2111712552 @default.
- W4292291574 cites W2119775317 @default.
- W4292291574 cites W2413552560 @default.
- W4292291574 cites W2413636075 @default.
- W4292291574 cites W2415041554 @default.
- W4292291574 cites W2519219211 @default.
- W4292291574 cites W2558674288 @default.
- W4292291574 cites W2562521254 @default.
- W4292291574 cites W2566459362 @default.
- W4292291574 cites W2595141737 @default.
- W4292291574 cites W2624789402 @default.
- W4292291574 cites W2728227150 @default.
- W4292291574 cites W2733307304 @default.
- W4292291574 cites W2745853250 @default.
- W4292291574 cites W2753603515 @default.
- W4292291574 cites W2760938773 @default.
- W4292291574 cites W2761792472 @default.
- W4292291574 cites W2766589848 @default.
- W4292291574 cites W2770778328 @default.
- W4292291574 cites W2783929654 @default.
- W4292291574 cites W2795373371 @default.
- W4292291574 cites W2796891281 @default.
- W4292291574 cites W2884077015 @default.
- W4292291574 cites W2891316367 @default.
- W4292291574 cites W2912677158 @default.
- W4292291574 cites W2914761223 @default.
- W4292291574 cites W2915228510 @default.
- W4292291574 cites W2915579267 @default.
- W4292291574 cites W2921728285 @default.
- W4292291574 cites W2945582672 @default.
- W4292291574 cites W2953814214 @default.
- W4292291574 cites W2955650241 @default.
- W4292291574 cites W2957912263 @default.
- W4292291574 cites W2972917577 @default.
- W4292291574 cites W2976525441 @default.
- W4292291574 cites W2976992969 @default.
- W4292291574 cites W2979193880 @default.
- W4292291574 cites W2984359187 @default.
- W4292291574 cites W2990882513 @default.
- W4292291574 cites W2995958153 @default.
- W4292291574 cites W3005447239 @default.
- W4292291574 cites W3013165212 @default.
- W4292291574 cites W3014458951 @default.
- W4292291574 cites W3014683777 @default.
- W4292291574 cites W3015759203 @default.
- W4292291574 cites W3017286296 @default.
- W4292291574 cites W3028143069 @default.
- W4292291574 cites W3035049698 @default.
- W4292291574 cites W3035278090 @default.
- W4292291574 cites W3036705592 @default.
- W4292291574 cites W3037451575 @default.
- W4292291574 cites W3047400464 @default.
- W4292291574 cites W3084409173 @default.
- W4292291574 cites W3093378950 @default.
- W4292291574 cites W3097335547 @default.
- W4292291574 cites W3121373553 @default.
- W4292291574 cites W3128362389 @default.
- W4292291574 cites W3131061841 @default.
- W4292291574 cites W3132934779 @default.
- W4292291574 cites W3146175886 @default.
- W4292291574 cites W3157332764 @default.
- W4292291574 cites W3163735470 @default.
- W4292291574 cites W3166447156 @default.
- W4292291574 cites W3166800172 @default.
- W4292291574 cites W3168380640 @default.
- W4292291574 cites W3171208153 @default.
- W4292291574 cites W3181446845 @default.
- W4292291574 cites W3183412957 @default.
- W4292291574 cites W3187855084 @default.
- W4292291574 cites W3195137400 @default.
- W4292291574 cites W3197690460 @default.
- W4292291574 cites W3199434334 @default.
- W4292291574 cites W3201235950 @default.
- W4292291574 cites W3203694275 @default.
- W4292291574 cites W3204397092 @default.
- W4292291574 cites W3206141883 @default.
- W4292291574 cites W3207854145 @default.